Sean Garvey

Dr. Sean Garvey

BIO-CAT, Inc., Charlottesville, Virginia, USA
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2009 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
JSJan Senderek
Jan Senderek
Sean GarveySean Garvey
Sean Garvey
MKMichael Krieger
Michael Krieger
VGVelina Guergueltcheva
Velina Guergueltcheva
AUAndoni Urtizberea
Andoni Urtizberea
CJCharles E. Jackson
Charles E. Jackson

1 February 2002 in Genomics
Verified
Journal Article
Closed access
Sean GarveySean Garvey
Sean Garvey
CRChandrika Rajan
Chandrika Rajan
ALAllen P. Lerner
Allen P. Lerner
WFWayne N. Frankel
Wayne N. Frankel
GCGregory A. Cox
Gregory A. Cox

2 May 2011 in Human Molecular Genetics
Verified
Journal Article
Closed access
PDF file
JSJane T. Seto
Jane T. Seto
MLMonkol Lek
Monkol Lek
KQKate G.R. Quinlan
Kate G.R. Quinlan
PHPeter Houweling
Peter Houweling
XZXi F. Zheng
Xi F. Zheng
Kathryn N. NorthKathryn N. North
Kathryn N. North
Sarcomeric α-actinins (α-actinin-2 and -3) are a major component of the Z-disk in skeletal muscle, where they crosslink actin and other structural proteins to maintain an ordered myofibrillar array. Homozygosity for the common null polymorphism (R577X) in ACTN3 results in the absence of fast fiber-specific α-actinin-3 in ∼20% of the general population. α-Actinin-3 deficiency is associated with decreased force generation and is detrimental to sprint and power performance in elite athletes, suggesting that α-actinin-3 is necessary for optimal forceful repetitive muscle contractions. Since Z-disks are the structures most vulnerable to eccentric damage, we sought to examine the effects of α-actinin-3 deficiency on sarcomeric integrity. Actn3 knockout mouse muscle showed significantly increased force deficits following eccentric contraction at 30% stretch, suggesting that α-actinin-3 deficiency results in an increased susceptibility to muscle damage at the extremes of muscle performance. Microarray analyses demonstrated an increase in muscle remodeling genes, which we confirmed at the protein level. The loss of α-actinin-3 and up-regulation of α-actinin-2 resulted in no significant changes to the total pool of sarcomeric α-actinins, suggesting that alterations in fast fiber Z-disk properties may be related to differences in functional protein interactions between α-actinin-2 and α-actinin-3. In support of this, we demonstrated that the Z-disk proteins, ZASP, titin and vinculin preferentially bind to α-actinin-2. Thus, the loss of α-actinin-3 changes the overall protein composition of fast fiber Z-disks and alters their elastic properties, providing a mechanistic explanation for the loss of force generation and increased susceptibility to eccentric damage in α-actinin-3-deficient individuals.

21 October 2022 in Gut Microbes
Verified
Journal Article
Open access
Sean GarveySean Garvey
Sean Garvey
EMEunice Mah
Eunice Mah
TBTraci M. Blonquist
Traci M. Blonquist
VKValerie N. Kaden
Valerie N. Kaden
JSJessica L Spears
Jessica L Spears
Durable spore-forming probiotics are increasingly formulated into foods, beverages, and dietary supplements. To help meet this demand, the safety and efficacy of daily supplementation of Bacillus subtilis BS50 for 6 weeks was investigated in a randomized, double-blind, placebo-controlled, parallel clinical trial of 76 healthy adults. Before and during supplementation, gastrointestinal symptoms were recorded daily using a multi-symptom questionnaire. Clinical chemistry, hematology, plasma lipids, and intestinal permeability and inflammation markers were measured at baseline and end of study. Compared to placebo, 2 × 109 colony-forming units (CFU) BS50 per day increased the proportion of participants showing improvement from baseline to week 6 in the composite score for bloating, burping, and flatulence (47.4% vs. 22.2%), whereby the odds of detecting an improvement were higher with BS50 (OR [95% CI]: 3.2 [1.1, 8.7], p = .024). Analyses of individual gastrointestinal symptoms indicate that BS50 increased the proportion of participants showing an improvement at week 6 compared to placebo for burping (44.7% vs. 22.2%, p = .041) and bloating (31.6% vs. 13.9%, p = .071), without affecting other symptoms. There were no clinically meaningful changes in clinical chemistry, hematology, plasma lipids and intestinal permeability and other inflammation markers. In conclusion, the results suggest that dietary supplementation of 2 × 109 CFU Bacillus subtilis BS50 per day is a well-tolerated and safe strategy to alleviate gas-related gastrointestinal symptoms in healthy adults.

9 September 2008 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
TCTodd J. Cohen
Todd J. Cohen
TBTomasa Barrientos
Tomasa Barrientos
ZHZachary C. Hartman
Zachary C. Hartman
Sean GarveySean Garvey
Sean Garvey
GCGregory A. Cox
Gregory A. Cox
TYTso‐Pang Yao
Tso‐Pang Yao
Histone deacetylase 4 (HDAC4) binds and inhibits activation of the critical muscle transcription factor myocyte enhancer factor‐2 (MEF2). However, the physiological significance of the HDAC4‐MEF2 complex in skeletal muscle has not been established. Here we show that in skeletal muscle, HDAC4 is a critical modulator of MEF2‐dependent structural and contractile gene expression in response to neural activity. We present evidence that loss of neural input leads to concomitant nuclear accumulation of HDAC4 and transcriptional reduction of MEF2‐regulated gene expression. Cell‐based assays show that HDAC4 represses structural gene expression via direct binding to AT‐rich MEF2 response elements. Notably, using both surgical denervation and the neuromuscular disease amyotrophic lateral sclerosis (ALS) model, we found that elevated levels of HDAC4 are required for efficient repression of MEF2‐dependent structural gene expression, indicating a link between the patho‐logical induction of HDAC4 and subsequent MEF2 target gene suppression. Supporting this supposition, we show that ectopic expression of HDAC4 in muscle fibers is sufficient to induce muscle damage in mice. Our study identifies HDAC4 as an activity‐dependent regulator of MEF2 function and suggests that activation of HDAC4 in response to chronically reduced neural activity suppresses MEF2‐dependent gene expression and contributes to progressive muscle dysfunction observed in neuromuscular diseases.—Cohen, T. J., Barrientos, T., Hartman, Z. C., Garvey, S. M., Cox, G. A., Yao, T.‐P. The deacetylase HDAC4 controls myocyte enhancing factor‐2 dependent structural gene expression in response to neural activity. FASEB J. 23, 99‐106 (2009)

21 April 2004 in Human Molecular Genetics
Verified
Journal Article
Closed access
TMTerry P Maddatu
Terry P Maddatu
Sean GarveySean Garvey
Sean Garvey
SGSean M Garvey
Sean M Garvey
DSDavid G Schroeder
David G Schroeder
THThomas G Hampton
Thomas G Hampton
GCGregory A Cox
Gregory A Cox
Immunoglobulin mu binding protein 2 (IGHMBP2) is a DNA/RNA helicase with a putative role in transcriptional regulation and splicing. A recessive mutation of the Ighmbp2 gene in neuromuscular degeneration (nmd) mice causes progressive neurogenic atrophy of limb muscles. Affected mice show significant loss of motor neurons with large caliber axons and a moderate reduction of neurons with small caliber axons in the ventral nerve roots of the spinal cord. To investigate the role of Ighmbp2 in the pathogenesis of neuromuscular degeneration, we generated two independent lines of transgenic mice expressing the full-length Ighmbp2 cDNA specifically in neurons. Histopathological evaluation of L4 ventral nerve roots revealed that transgenic expression of the Ighmbp2 cDNA prevented primary motor neuron degeneration, while restoring the normal axonal morphology and density in nmd mice. A similar neuronal improvement is found in mutant mice carrying the CAST/EiJ-derived modifier of nmd (Mnm(C)). Intriguingly, both the transgenic and modified nmd mice went on to develop a previously unobserved cardiac and skeletal myopathy. Necropsy of nmd mice in end-stage heart failure revealed a primary dilated cardiomyopathy with secondary respiratory failure that was confirmed by in vivo ECG and echocardiographic measures. Our results suggest that reduced levels of IGHMBP2 in nmd mice compromise the integrity and function not only of motor neurons but also of skeletal and cardiac myocytes. These findings highlight the important role of IGHMBP2 in the maintenance and survival of these terminally differentiated cell types.